Gujarat: The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover and 28 percent of its pharmaceutical exports. Given the…
Established in 1977, Entod has always shown a strong commitment to Innovation & Quality in Ophthalmic, ENT and Paediatric medicines. Our commitment and dedication to consistently achieve the HIGHEST QUALITY INTERNATIONAL STANDARDS has won us the trust of many in the ophthalmic, ENT and respiratory fraternity.
Entod has been committed in collaborating with various medical fraternities in support of educational and professional development programmes and conferences. We want to make a real difference to medical practice and to the quality of medical care received by patients.
We incorporate the latest TECHNOLOGIES in pharmaceutical manufacturing and are proud that our products are manufactured at state-of-the-art internationally approved manufacturing facilities.
Entod is continually expanding its innovative product range, rapidly developing its R&D facilities and growing its sales field force globally. With several exciting new products, research projects and clinical initiatives in the pipeline, Entod´s global image is taking good shape.
Contact:
Address: Ashirwad building, S.V.Road, Opp. Badi Masjid, Bandra(W), Mumbai-400050 INDIA
Website: entodpharma.com
Email: feedback@entodpharma.com
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover and 28 percent of its pharmaceutical exports. Given the…
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the life sciences industry as head of Piramal Pharma Solutions (PPS) in…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports to developed nations, are increasingly forging closer links. With US trade tariffs affecting both…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s ambitious healthcare insurance scheme, “Modicare” and delves into some of its critical challenges and associated…
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more empowered regulator in India if the country is to build public confidence in its pharma output…
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe, hence the reason India has been dubbed ‘ the pharmacy to the world.’ Furthermore,…
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the meantime – been rapidly…
In a context where even well-established, multi-billion-dollar domestic companies have received warning letters from the US FDA, quality compliance has clearly become strategically important across all layers of Indian organizations,…
One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance. With a number of pharma manufacturers the recipients of warning letters from the…
Bhupendra Sangani, founder and managing director of Galentic, one of India’s expert manufacturers of sterile and non-sterile semi-solid products in the dermatology and ophthalmology arenas, provides insights into the international…
Dr. Satyanarayana Chava, founder and CEO of Laurus Labs, provides insights into the distinctive model that has allowed Laurus to become one of the world’s leading API companies as well…
Luca Visini, the recently appointed managing director of Eli Lilly & Company for India, shares with us his first perspective of the Indian ecosystem He also provides insights into some…
See our Cookie Privacy Policy Here
